Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China
· Delayed Price · Currency is CNY 52.41
-0.14 (-0.27%)
Apr 30, 2025, 3:04 PM CST
SHE:300832 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 41,180 | 55,668 | 61,443 | 39,416 | 34,652 | 54,455 | Upgrade
|
| Market Cap Growth | -11.97% | -9.40% | 55.88% | 13.75% | -36.36% | - | Upgrade
|
| Enterprise Value | 38,705 | 53,087 | 58,196 | 36,274 | 31,451 | 51,757 | Upgrade
|
| Last Close Price | 52.41 | 70.85 | 77.18 | 48.89 | 42.35 | 66.29 | Upgrade
|
| PE Ratio | 22.38 | 30.45 | 37.16 | 29.68 | 35.59 | 57.98 | Upgrade
|
| Forward PE | 19.76 | 25.23 | 31.02 | 27.83 | 28.70 | 47.78 | Upgrade
|
| PS Ratio | 8.88 | 12.27 | 15.64 | 12.94 | 13.61 | 24.81 | Upgrade
|
| PB Ratio | 4.57 | 6.49 | 8.14 | 6.16 | 6.18 | 11.34 | Upgrade
|
| P/TBV Ratio | 4.70 | 6.68 | 8.33 | 6.33 | 6.28 | 11.57 | Upgrade
|
| P/FCF Ratio | 54.65 | 60.69 | 56.06 | 70.49 | 80.54 | 75.44 | Upgrade
|
| P/OCF Ratio | 36.99 | 41.04 | 43.32 | 40.96 | 44.82 | 55.76 | Upgrade
|
| EV/Sales Ratio | 8.34 | 11.71 | 14.81 | 11.91 | 12.36 | 23.58 | Upgrade
|
| EV/EBITDA Ratio | 18.27 | 25.17 | 30.83 | 25.11 | 27.32 | 46.98 | Upgrade
|
| EV/EBIT Ratio | 20.06 | 27.49 | 33.49 | 27.22 | 29.74 | 50.61 | Upgrade
|
| EV/FCF Ratio | 51.37 | 57.88 | 53.09 | 64.87 | 73.10 | 71.70 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0.00 | 0 | 0 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | - | Upgrade
|
| Asset Turnover | 0.51 | 0.51 | 0.52 | 0.46 | 0.45 | 0.50 | Upgrade
|
| Inventory Turnover | 1.31 | 1.20 | 1.21 | 1.22 | 1.33 | 1.44 | Upgrade
|
| Quick Ratio | 6.02 | 4.13 | 6.96 | 6.73 | 7.31 | 7.30 | Upgrade
|
| Current Ratio | 8.42 | 5.56 | 8.56 | 8.26 | 8.85 | 8.37 | Upgrade
|
| Return on Equity (ROE) | 21.68% | 22.68% | 23.72% | 22.11% | 18.70% | 23.65% | Upgrade
|
| Return on Assets (ROA) | 13.17% | 13.53% | 14.26% | 12.67% | 11.55% | 14.59% | Upgrade
|
| Return on Capital (ROIC) | 14.20% | 14.97% | 15.57% | 13.87% | 12.69% | 16.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.10% | 22.20% | 22.80% | 20.70% | 18.80% | 21.20% | Upgrade
|
| Earnings Yield | 4.47% | 3.28% | 2.69% | 3.37% | 2.81% | 1.73% | Upgrade
|
| FCF Yield | 1.83% | 1.65% | 1.78% | 1.42% | 1.24% | 1.33% | Upgrade
|
| Dividend Yield | 2.48% | 1.84% | 1.30% | 1.43% | 1.42% | 1.98% | Upgrade
|
| Payout Ratio | 42.74% | 42.98% | 33.15% | 35.53% | 42.46% | 65.91% | Upgrade
|
| Buyback Yield / Dilution | -0.00% | 0.01% | 0.07% | -0.04% | -4.76% | -6.61% | Upgrade
|
| Total Shareholder Return | 2.48% | 1.85% | 1.36% | 1.39% | -3.34% | -4.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.